APG Asset Management
BIO icon

APG Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

APG Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,305
Closed -$3.65M – 438
2024
Q2 		$3.65M Buy
14,305
+96
+0.7% +$27.9K 0.01% 489
2024
Q1 		$4.55M Sell
14,209
-1,573
-10% -$517K 0.01% 477
2023
Q4 		$4.61M Sell
15,782
-1,752
-10% -$549K 0.01% 480
2023
Q3 		$6.29M Sell
17,534
-1,841
-10% -$710K 0.01% 456
2023
Q2 		$6.73M Sell
19,375
-630
-3% -$256K 0.01% 449
2023
Q1 		$8.82M Sell
20,005
-3,100
-13% -$1.45M 0.02% 435
2022
Q4 		$9.71M Buy
23,105
+16,794
+266% +$6.78M 0.02% 453
2022
Q3 		$2.69M Sell
6,311
-2,258
-26% -$1.13M 0.01% 510
2022
Q2 		$4.06M Sell
8,569
-52,904
-86% -$27.6M 0.01% 467
2022
Q1 		$31.1M Sell
61,473
-50,372
-45% -$30.4M 0.06% 300
2021
Q4 		$74.3M Sell
111,845
-300
-0.3% -$225K 0.13% 190
2021
Q3 		$72.2M Sell
112,145
-800
-0.7% -$599K 0.13% 187
2021
Q2 		$61.4M Buy
112,945
+5,600
+5% +$3.41M 0.1% 223
2021
Q1 		$52.2M Buy
107,345
+22,173
+26% +$13.1M 0.09% 263
2020
Q4 		$40.6M Buy
85,172
+42,229
+98% +$24M 0.07% 298
2020
Q3 		$18.9M Buy
42,943
+18,735
+77% +$9.49M 0.03% 445
2020
Q2 		$9.73M Sell
24,208
-1,200
-5% -$530K 0.02% 569
2020
Q1 		$8.91M Buy
25,408
+10,408
+69% +$3.83M 0.02% 573
2019
Q4 		$4.95M Buy
+15,000
New +$5.29M 0.01% 697

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

APG Asset Management's BIO Position: Q3 2024 in Review

APG Asset Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2024, closing a stake of 14,305 shares — an estimated $3.65M sold.

APG Asset Management first reported a position in BIO in Q4 2019 and held it in 19 quarters. The position peaked at $74.3M in Q4 2021. 437 funds tracked by Wall St. Rank hold BIO as of Q3 2024.

  • APG Asset Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2024 after selling out during the quarter.
  • APG Asset Management sold 14,305 Bio-Rad Laboratories Class A shares in Q3 2024, an estimated $3.65M.
  • APG Asset Management first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 19 quarters.
  • APG Asset Management's Bio-Rad Laboratories Class A position peaked at $74.3M in Q4 2021.
  • 437 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2024.

Based on APG Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.